Carl A Samuelson

Title: The Innovations of Carl A. Samuelson

Introduction

Carl A. Samuelson is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit platelet aggregation. His work is crucial for advancing treatments for various diseases associated with thrombosis and related disorders.

Latest Patents

Samuelson holds a patent for "Orally bioavailable compounds and methods for inhibiting platelet aggregation." This invention focuses on a method to prevent or treat conditions linked to platelet aggregation. The method involves administering a pharmaceutical composition that includes a non-nucleotide compound, specifically a P2Y receptor antagonist. The compounds developed under this patent are characterized by their potency and good oral bioavailability, making them effective in clinical applications.

Career Highlights

Throughout his career, Samuelson has been associated with Inspire Pharmaceuticals, Inc., where he has contributed to innovative research and development. His expertise in pharmacology and drug formulation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Samuelson has worked alongside esteemed colleagues such as James G. Douglass, III and Paul Steven Watson. Their collaborative efforts have furthered the research and development of novel pharmaceutical compounds.

Conclusion

Carl A. Samuelson's contributions to the field of pharmaceuticals, particularly through his patent on orally bioavailable compounds, highlight his role as an influential inventor. His work continues to impact the treatment of diseases related to platelet aggregation.